2D versus 3D laparoscopic total mesorectal excision: a developmental multicentre randomised controlled trial

[1] Nagtegaal ID(2002)Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control J Clin Oncol 20 1729-1734

[2] van de Velde CJ(2009)Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial Lancet 373 821-828

[3] van der Worp E(1986)Recurrence and survival after total mesorectal excision for rectal cancer Lancet 1 1479-1482

[4] Kapiteijn E(2015)Scoring the quality of total mesorectal excision for the prediction of cancer-specific outcome Colorectal Dis 17 O115-O122

[5] Quirke P(2018)Association of plane of total mesorectal excision with prognosis of rectal cancer: secondary analysis of the CAO/ARO/AIO-04 phase 3 randomized clinical trial JAMA Surg 372 1324-1332

[6] van Krieken JH(2015)A randomized trial of laparoscopic versus open surgery for rectal cancer N Engl J Med 15 767-774

[7] Quirke P(2014)Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial Lancet Oncol 314 1356-1363

[8] Steele R(2015)Effect of laparoscopic-assisted resection versus open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial JAMA 314 1346-1355

[9] Monson J(2015)Effect of laparoscopic-assisted resection versus open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial JAMA 11 637-645

[10] Grieve R(2010)Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial Lancet Oncol 9 368-377

[1] Nagtegaal ID(2002)Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control J Clin Oncol 20 1729-1734

[2] van de Velde CJ(2009)Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial Lancet 373 821-828

[3] van der Worp E(1986)Recurrence and survival after total mesorectal excision for rectal cancer Lancet 1 1479-1482

[4] Kapiteijn E(2015)Scoring the quality of total mesorectal excision for the prediction of cancer-specific outcome Colorectal Dis 17 O115-O122

[5] Quirke P(2018)Association of plane of total mesorectal excision with prognosis of rectal cancer: secondary analysis of the CAO/ARO/AIO-04 phase 3 randomized clinical trial JAMA Surg 372 1324-1332

[6] van Krieken JH(2015)A randomized trial of laparoscopic versus open surgery for rectal cancer N Engl J Med 15 767-774

[7] Quirke P(2014)Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial Lancet Oncol 314 1356-1363

[8] Steele R(2015)Effect of laparoscopic-assisted resection versus open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial JAMA 314 1346-1355

[9] Monson J(2015)Effect of laparoscopic-assisted resection versus open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial JAMA 11 637-645

[10] Grieve R(2010)Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial Lancet Oncol 9 368-377